Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler

被引:19
作者
Patel, S
Zuckerman, M
Smith, M
机构
[1] Kings Coll Hosp London, Guys Kings & St Thomas Sch Med, Dept Virol, S London Publ Hlth Lab, London SE22 8QF, England
[2] Kings Coll Hosp London, Guys Kings & St Thomas Sch Med, Dept Virol, Dept Infect, London SE22 8QF, England
关键词
Epstein-Barr virus; real-time quantitative PCR; BZLF1;
D O I
10.1016/S0166-0934(03)00076-4
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Epstein-Barr virus (EBV) is associated with the development of lymphoproliferative disorders in the immunocompromised host and in particular post-transplant recipients. The development of a rapid real-time quantitative PCR for the detection of the immediate early gene BZLF1 is described using the Roche LightCycler. BZLF1 codes for the ZEBRA protein, one of the cascade of transactivation factors involved in the lytic life cycle of the virus. The assay is rapid and can detect a single copy of EBV DNA. Intra- and inter-assay variability studies using the external quantitative standards and DNA extracted from whole blood and plasma samples were shown to be within a 0.5 log(10) range. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:227 / 233
页数:7
相关论文
共 25 条
  • [1] Bai X, 1997, CLIN CHEM, V43, P1843
  • [2] High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders
    Baldanti, F
    Grossi, P
    Furione, M
    Simoncini, L
    Sarasini, A
    Comoli, P
    Maccario, R
    Fiocchi, R
    Gerna, G
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (02) : 613 - 619
  • [3] Epstein-Barr virus infection in sixty pediatric liver graft recipients:: diagnosis of primary infection and virologic follow-up
    Bodéus, M
    Smets, F
    Reding, R
    Sokal, E
    Otte, JB
    Goubau, P
    van Renterghem, L
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (08) : 698 - 702
  • [4] Routine use of real-time quantitative PCR for laboratory diagnosis of Epstein-Barr virus infections
    Brengel-Pesce, K
    Morand, P
    Schmuck, A
    Bourgeat, MJ
    Buisson, M
    Barguès, G
    Bouzid, M
    Seigneurin, JM
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (03) : 360 - 369
  • [5] POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RENAL-ALLOGRAFT RECIPIENTS - CLINICAL-EXPERIENCE AND RISK FACTOR-ANALYSIS IN A SINGLE-CENTER
    COCKFIELD, SM
    PREIKSAITIS, JK
    JEWELL, LD
    PARFREY, NA
    [J]. TRANSPLANTATION, 1993, 56 (01) : 88 - 96
  • [6] Epstein-Barr virus-related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression
    Ellis, D
    Jaffe, R
    Green, M
    Janosky, JJ
    Lombardozzi-Lane, S
    Shapiro, R
    Scantlebury, V
    Vivas, C
    Jordan, ML
    [J]. TRANSPLANTATION, 1999, 68 (07) : 997 - 1003
  • [7] ANTI-B-CELL MONOCLONAL-ANTIBODIES IN THE TREATMENT OF SEVERE B-CELL LYMPHOPROLIFERATIVE SYNDROME FOLLOWING BONE-MARROW AND ORGAN-TRANSPLANTATION
    FISCHER, A
    BLANCHE, S
    LEBIDOIS, J
    BORDIGONI, P
    GARNIER, JL
    NIAUDET, P
    MORINET, F
    LEDEIST, F
    FISCHER, AM
    GRISCELLI, C
    HIRN, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21) : 1451 - 1456
  • [8] Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease
    Gärtner, BC
    Schäffer, H
    Marggraff, K
    Eisele, G
    Schäfer, M
    Roemer, K
    Laws, HJ
    Sester, M
    Sester, U
    Einsele, H
    Mueller-Lantzsch, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (02) : 351 - 358
  • [9] HENLE W, 1981, CANCER RES, V41, P4222
  • [10] Hsieh W S, 1999, Transpl Infect Dis, V1, P204, DOI 10.1034/j.1399-3062.1999.010308.x